SHUMIN ZHEN: Open Payments
NPI 1043486491 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,691 in 49 payments from 17 companies in 2025. Trend: 2023 $1,382 · 2024 $1,505 · 2025 $1,691
Food & beverage: $1,691
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $572 |
| Novartis Pharmaceuticals Corporation | 12 | $230 |
| Merck Sharp & Dohme LLC | 6 | $181 |
| Alnylam Pharmaceuticals Inc. | 5 | $134 |
| AstraZeneca Pharmaceuticals LP | 4 | $103 |
| Kestra Medical Technology Services, Inc. | 4 | $83 |
| PFIZER INC. | 4 | $76 |
| Amgen Inc. | 3 | $52 |
| Abbott Laboratories | 2 | $49 |
| ABIOMED | 1 | $44 |
Products named: Rapiblyk, LEQVIO, VERQUVO, AMVUTTRA, WAINUA, Assure WCD, ELIQUIS, REPATHA.
Industry payments across CA — which companies pay providers there.
